| Name | Title | Contact Details |
|---|
More than 20,000 genes make us human. Genes control critical aspects of health and disease — but what controls our genes? Foghorn® Therapeutics ($FHTX) is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order. By manipulating this system with our unique Gene Traffic Control™ platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease. With Gene Traffic Control™ Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.
Austill's specializes in providing pediatric therapy services to School Districts, Early Intervention Programs, and County-Wide Regional Special Education providers. Since 1984, Austill's has provided therapy for educational programs. We customize all
Carolina Centers for Medical Excellence is a Cary, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Detroit Institute for Children is a Detroit, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Pyx Health is leading the solution to Loneliness and Social Isolation through technology and human connection.